Hopeful price surge in Follicum after suspected analysis error in hair loss project

Many people's hopes for Follicum's hair loss project were dashed in May when the company presented top line results in which the drug candidate FOL-005 showed no...

June 3th, 2021

Follicum's new CEO on the next step in the company's development journey

Kim Arvid Nielsen recently took over as CEO of...

20th of May 2021

All patients have completed treatment in Follicum's phase IIa study

For Follicum, one of the big events of the year is coming...

February 1

Follicum one step closer to Phase III in 2021

Follicum has had a productive year that culminates...

December 17

Follicum's CEO comments on the private placement of SEK 37 million

Last week it was announced that the biotechnology company Follicum is conducting...

November 2

BioStock Studio: Follicum aims for partnership

When Follicum CEO Jan Alenfall visited BioStock's studio...

19 October 2020

Follicum completes patient recruitment in hair study

People affected by alopecia only have one...

9 October 2020

Follicum reaches milestone in hair study

Yesterday it was announced that Follicum has now recruited over...

August 19

New patent announcement rounds off eventful six months for Follicum

During the first half of 2020, Follicum has begun...

June 25th, 2020

BioStock studio: Follicum resumes hair study

In March, Follicum was forced to pause recruitment for its...

June 8th, 2020

Follicum applies for a broadened patent for topical formulation

Peptide company Follicum has filed an international patent application...

12th of May 2020

Hair loss has psychosocial consequences

Hair loss is a benign condition with limited physical...

27th April 2020

NEWSLETTER

You deserve the best!

Unlock our premium content: Become a subscriber!

Create Account

Tip the editors